Topline data were announced from 2 phase 3 trials evaluating MR-107A-02 for the treatment of moderate to severe acute pain.

Pain complaints among hospitalized patients with COVID-19 were negatively correlated with emergency intubation.

After pain, nausea and vomiting are the most documented symptoms in patients with cancer preceding unplanned acute care ...

A study conducted at the State University of Campinas (UNICAMP) in Brazil investigated the process of muscle pain ...

A version of meloxicam designed to work faster has beat out a placebo in two late-stage studies focused on post-surgical ...

Viatris (NASDAQ:VTRS) stock rises 5% premarket as Phase 3 trials show success for non-opioid pain therapy, meloxicam as a ...

Viatris said on Thursday that its fast-acting form of generic pain drug meloxicam met the main goals of two late-stage studies.

Vertex Pharmaceuticals sees brighter prospects despite Q1 misses, with promising launches, pipeline progress, and upgraded ...

A large U.S. cohort study found that post-acute symptoms after COVID-19 vary by initial disease severity, age, sex, and ...

Discover how the transverse abdominis, your body's natural internal back brace, could be the unaddressed root cause of your ...

Here's why this muscle deserves more attention—and how to strengthen it. Lower back pain is often blamed on posture or pulled muscles—but the real cause may be deeper. Experts point to a deep ...